Massachusetts Financial Services Portfolio holdings
Massachusetts Financial Services (MFS), founded in 1924 and headquartered in Boston, Massachusetts, is a pioneering investment management firm credited with launching the first U.S. mutual fund, the Massachusetts Investors Trust. Managing hundreds of billions in assets, MFS offers a wide range of actively managed investment products, including equity, fixed-income, and balanced funds, serving institutional investors, financial advisors, and individuals globally. Known for its disciplined, research-driven approach, the firm emphasizes long-term value creation through fundamental analysis and a collaborative team structure, avoiding short-term market trends. With a legacy of innovation and a strong global presence, MFS remains a respected name in the asset management industry, balancing tradition with a focus on sustainable, client-centric investing.
Top Buys
| 1 |
Exxon Mobil
XOM
|
+$1.63B |
| 2 |
Qualcomm
QCOM
|
+$607M |
| 3 |
GE Aerospace
GE
|
+$580M |
| 4 |
Salesforce
CRM
|
+$494M |
| 5 |
Chevron
CVX
|
+$477M |
Top Sells
| 1 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$1.69B |
| 2 |
Comcast
CMCSA
|
+$1.26B |
| 3 |
Boston Scientific
BSX
|
+$1.14B |
| 4 |
NVIDIA
NVDA
|
+$1.03B |
| 5 |
Flutter Entertainment
FLUT
|
+$828M |
Sector Composition
| 1 | Technology | 23.99% |
| 2 | Financials | 18.51% |
| 3 | Healthcare | 12.55% |
| 4 | Industrials | 12.27% |
| 5 | Consumer Discretionary | 6.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
601
Ardagh Metal Packaging
AMBP
$2.1B
| $15.5M | ﹤0.01% |
4,554,950
-1,685,029
| -27% | -$5.73M |
|
602
Burlington
BURL
$17.6B
| $15.3M | ﹤0.01% |
63,590
-17,923
| -22% | -$4.3M |
|
603
Ultragenyx Pharmaceutical
RARE
$3.02B
| $15.2M | ﹤0.01% |
370,247
+103,280
| +39% | +$4.24M |
|
604
BridgeBio Pharma
BBIO
$10.1B
| $15.2M | ﹤0.01% |
598,263
+219,257
| +58% | +$5.55M |
|
605
United Airlines
UAL
$35B
| $15.1M | ﹤0.01% |
311,092
+8,231
| +3% | +$401K |
|
606
Cytokinetics
CYTK
$6.11B
| $15M | ﹤0.01% |
+276,067
| New | +$15M |
|
607
Floor & Decor
FND
$9.13B
| $15M | ﹤0.01% |
+150,414
| New | +$15M |
|
608
Watts Water Technologies
WTS
$9.27B
| $14.3M | ﹤0.01% |
77,881
+335
| +0.4% | +$61.4K |
|
609
NRG Energy
NRG
$31.1B
| $14.2M | ﹤0.01% |
182,569
+25,563
| +16% | +$1.99M |
|
610
Adaptive Biotechnologies
ADPT
$1.92B
| $14.2M | ﹤0.01% |
3,912,027
+1,319,709
| +51% | +$4.78M |
|
611
Tesla
TSLA
$1.13T
| $14.1M | ﹤0.01% |
71,291
-27,523
| -28% | -$5.45M |
|
612
CryoPort
CYRX
$488M
| $14.1M | ﹤0.01% |
2,035,586
+52,103
| +3% | +$360K |
|
613
Roper Technologies
ROP
$55.2B
| $13.9M | ﹤0.01% |
24,631
+106
| +0.4% | +$59.7K |
|
614
Chewy
CHWY
$14.3B
| $13.7M | ﹤0.01% |
503,417
-1,890,157
| -79% | -$51.5M |
|
615
Endava
DAVA
$518M
| $13.5M | ﹤0.01% |
460,648
-8,302
| -2% | -$243K |
|
616
Cardinal Health
CAH
$35.9B
| $13.4M | ﹤0.01% |
136,701
-20,191
| -13% | -$1.99M |
|
617
IBM
IBM
$238B
| $13.3M | ﹤0.01% |
77,189
+9,155
| +13% | +$1.58M |
|
618
Immunocore
IMCR
$1.8B
| $13.2M | ﹤0.01% |
390,565
+79,444
| +26% | +$2.69M |
|
|
XYZ
619
Block, Inc.
XYZ
$44.7B
| $12.9M | ﹤0.01% |
199,859
-1,617
| -0.8% | -$104K |
|
620
Monro
MNRO
$502M
| $12.7M | ﹤0.01% |
532,763
-9,601
| -2% | -$229K |
|
621
Okta
OKTA
$15.9B
| $12.6M | ﹤0.01% |
+134,783
| New | +$12.6M |
|
622
Viking Therapeutics
VKTX
$2.83B
| $12.5M | ﹤0.01% |
236,601
-56,984
| -19% | -$3.02M |
|
623
Magna International
MGA
$13B
| $12.3M | ﹤0.01% |
293,540
+190
| +0.1% | +$7.96K |
|
624
Kymera Therapeutics
KYMR
$3.14B
| $12.1M | ﹤0.01% |
405,870
+10,731
| +3% | +$320K |
|
625
Altice USA
ATUS
$1.08B
| $11.6M | ﹤0.01% |
5,669,487
+24,501
| +0.4% | +$50K |
|